Mary Ann Liebert, Inc., publishers has announced the appointment of Professor Hana El-Samad as the Editor-in-Chief of its new marquee journal GEN Biotechnology, launching in early 2022. Leveraging the outstanding biotechnology network built by Genetic Engineering and Biotechnology News (GEN) over the past 40 years, GEN Biotechnology aims to be the premier peer-reviewed journal publishing outstanding original research and perspectives across all facets of the biotech industry.
Professor El-Samad is currently the Kuo Family Endowed Professor and Vice Chair in the Department of Biochemistry and Biophysics at the University of California, San Francisco (UCSF).
Through a combination of theory and experiments, Dr. El-Samad’s research seeks to understand the operational principles of biological networks. Her lab designs programmable, plug-and-play cellular circuits that can be broadly deployed for therapeutic and biotechnological applications, including cell-based immunotherapies, metabolic engineering, and bioremediation.
Dr. El-Samad is the recipient of numerous prestigious awards including the Donald P. Eckman Award in 2011 and the CSB2 prize in Systems Biology in 2012. She is a former Packard Fellow, a Paul. G. Allen Distinguished Investigator and was named a senior investigator of the Chan-Zuckerberg Biohub in 2017. In 2020, Dr. El-Samad was elected as an American Institute for Medical and Biological Engineering (AIMBE) fellow.
GEN Biotechnology will publish groundbreaking research in all aspects of biotechnology, including agbiotech, drug discovery, gene therapy, environmental biotechnology, precision medicine, single-cell biology, and more. In addition, GEN Biotechnology will feature an array of provocative front matter content including editorials, analyses, and commentary.
Dr. El-Samad will lead a growing international editorial advisory board of diverse visionaries in biotech who have thrown their support behind GEN Biotechnology, including Kiana Aran (Keck Graduate Institute), Lola Eniola-Adefeso (University of Michigan), Rong Fan (Yale School of Medicine), Karmella Haynes (Emory University),Christopher Mason (Weill Cornell Medicine), Laura Soucek (VHIO, Barcelona), Tom Ellis (Imperial College, London), Tejal Desai (UCSF), and Fyodor Urnov (Innovative Genomics Institute).
GEN Biotechnology is actively recruiting research papers for its inaugural issue, which will be published in early 2022. Pre-submission inquiries can be sent to editor@genbiotechjournal.com.
Click here to read the original press release.
